HEADER TRANSCRIPTION 23-MAR-22 7UG5 TITLE SECOND BROMODOMAIN OF BRD3 LIGANDED WITH BMS-536924 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 3; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: RING3-LIKE PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD3, KIAA0043, RING3L; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BROMODOMAIN, SMALL MOLECULE LIGAND, COMPLEX, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR E.SCHONBRUNN,M.BIKOWITZ REVDAT 2 25-OCT-23 7UG5 1 REMARK REVDAT 1 05-APR-23 7UG5 0 JRNL AUTH E.SCHONBRUNN,M.BIKOWITZ JRNL TITL STRUCTURAL BASIS OF CBP AND EP300 INTERACTION WITH KINASE JRNL TITL 2 INHIBITORS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19_4092 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.80 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 56000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1121 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.8000 - 3.5900 1.00 6956 142 0.1646 0.1856 REMARK 3 2 3.5900 - 2.8600 1.00 6897 141 0.1690 0.2118 REMARK 3 3 2.8500 - 2.4900 1.00 6828 140 0.1798 0.2267 REMARK 3 4 2.4900 - 2.2700 1.00 6882 140 0.1889 0.2452 REMARK 3 5 2.2700 - 2.1000 1.00 6831 139 0.1983 0.2318 REMARK 3 6 2.1000 - 1.9800 1.00 6831 140 0.2193 0.2544 REMARK 3 7 1.9800 - 1.8800 1.00 6836 139 0.2562 0.2586 REMARK 3 8 1.8800 - 1.8000 0.99 6818 140 0.3197 0.3857 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.210 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7UG5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-MAR-22. REMARK 100 THE DEPOSITION ID IS D_1000264125. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-20 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.03319 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56001 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 19.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 7L9L REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05M MAGNESIUM CHLORIDE HEXAHYDRATE, REMARK 280 0.1M HEPES PH7.5, 30% V/V POLYETHYLENE GLYCOL MONOMETHYL ETHER REMARK 280 550, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 52.29500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.14000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 52.29500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 46.14000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH C 717 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 306 REMARK 465 GLY C 306 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 307 CG CD CE NZ REMARK 470 LYS A 325 CG CD CE NZ REMARK 470 GLU A 341 CG CD OE1 OE2 REMARK 470 GLN A 374 CG CD OE1 NE2 REMARK 470 LYS B 307 CG CD CE NZ REMARK 470 GLU B 341 CG CD OE1 OE2 REMARK 470 LYS C 325 CG CD CE NZ REMARK 470 LYS C 403 CG CD CE NZ REMARK 470 GLU D 310 CG CD OE1 OE2 REMARK 470 LYS D 325 CG CD CE NZ REMARK 470 LYS D 403 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH C 641 O HOH C 713 2.03 REMARK 500 OE2 GLU C 341 O HOH C 601 2.05 REMARK 500 NZ LYS C 389 O HOH C 602 2.11 REMARK 500 O HOH B 712 O HOH D 618 2.13 REMARK 500 OE1 GLU A 369 O HOH A 601 2.14 REMARK 500 O HOH C 673 O HOH C 747 2.16 REMARK 500 O HOH A 702 O HOH A 739 2.18 REMARK 500 O HOH D 724 O HOH D 727 2.19 REMARK 500 O1 EDO C 503 O HOH C 603 2.19 REMARK 500 O HOH A 712 O HOH C 682 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 697 O HOH D 657 4556 2.12 REMARK 500 O HOH A 696 O HOH C 701 4555 2.15 REMARK 500 O HOH A 710 O HOH D 652 4556 2.16 REMARK 500 O HOH A 632 O HOH D 616 4556 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 345 65.07 -107.00 REMARK 500 LEU B 345 67.34 -110.26 REMARK 500 LYS D 307 -24.48 -158.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 741 DISTANCE = 6.06 ANGSTROMS REMARK 525 HOH B 744 DISTANCE = 5.85 ANGSTROMS REMARK 525 HOH B 745 DISTANCE = 6.01 ANGSTROMS REMARK 525 HOH B 746 DISTANCE = 6.56 ANGSTROMS REMARK 525 HOH C 755 DISTANCE = 6.41 ANGSTROMS REMARK 525 HOH D 734 DISTANCE = 6.51 ANGSTROMS DBREF 7UG5 A 306 416 UNP Q15059 BRD3_HUMAN 306 416 DBREF 7UG5 B 306 416 UNP Q15059 BRD3_HUMAN 306 416 DBREF 7UG5 C 306 416 UNP Q15059 BRD3_HUMAN 306 416 DBREF 7UG5 D 306 416 UNP Q15059 BRD3_HUMAN 306 416 SEQRES 1 A 111 GLY LYS LEU SER GLU HIS LEU ARG TYR CYS ASP SER ILE SEQRES 2 A 111 LEU ARG GLU MET LEU SER LYS LYS HIS ALA ALA TYR ALA SEQRES 3 A 111 TRP PRO PHE TYR LYS PRO VAL ASP ALA GLU ALA LEU GLU SEQRES 4 A 111 LEU HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO MET ASP SEQRES 5 A 111 LEU SER THR VAL LYS ARG LYS MET ASP GLY ARG GLU TYR SEQRES 6 A 111 PRO ASP ALA GLN GLY PHE ALA ALA ASP VAL ARG LEU MET SEQRES 7 A 111 PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS GLU SEQRES 8 A 111 VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE GLU SEQRES 9 A 111 MET ARG PHE ALA LYS MET PRO SEQRES 1 B 111 GLY LYS LEU SER GLU HIS LEU ARG TYR CYS ASP SER ILE SEQRES 2 B 111 LEU ARG GLU MET LEU SER LYS LYS HIS ALA ALA TYR ALA SEQRES 3 B 111 TRP PRO PHE TYR LYS PRO VAL ASP ALA GLU ALA LEU GLU SEQRES 4 B 111 LEU HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO MET ASP SEQRES 5 B 111 LEU SER THR VAL LYS ARG LYS MET ASP GLY ARG GLU TYR SEQRES 6 B 111 PRO ASP ALA GLN GLY PHE ALA ALA ASP VAL ARG LEU MET SEQRES 7 B 111 PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS GLU SEQRES 8 B 111 VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE GLU SEQRES 9 B 111 MET ARG PHE ALA LYS MET PRO SEQRES 1 C 111 GLY LYS LEU SER GLU HIS LEU ARG TYR CYS ASP SER ILE SEQRES 2 C 111 LEU ARG GLU MET LEU SER LYS LYS HIS ALA ALA TYR ALA SEQRES 3 C 111 TRP PRO PHE TYR LYS PRO VAL ASP ALA GLU ALA LEU GLU SEQRES 4 C 111 LEU HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO MET ASP SEQRES 5 C 111 LEU SER THR VAL LYS ARG LYS MET ASP GLY ARG GLU TYR SEQRES 6 C 111 PRO ASP ALA GLN GLY PHE ALA ALA ASP VAL ARG LEU MET SEQRES 7 C 111 PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS GLU SEQRES 8 C 111 VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE GLU SEQRES 9 C 111 MET ARG PHE ALA LYS MET PRO SEQRES 1 D 111 GLY LYS LEU SER GLU HIS LEU ARG TYR CYS ASP SER ILE SEQRES 2 D 111 LEU ARG GLU MET LEU SER LYS LYS HIS ALA ALA TYR ALA SEQRES 3 D 111 TRP PRO PHE TYR LYS PRO VAL ASP ALA GLU ALA LEU GLU SEQRES 4 D 111 LEU HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO MET ASP SEQRES 5 D 111 LEU SER THR VAL LYS ARG LYS MET ASP GLY ARG GLU TYR SEQRES 6 D 111 PRO ASP ALA GLN GLY PHE ALA ALA ASP VAL ARG LEU MET SEQRES 7 D 111 PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS GLU SEQRES 8 D 111 VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE GLU SEQRES 9 D 111 MET ARG PHE ALA LYS MET PRO HET N6I A 501 34 HET EDO A 502 4 HET EDO A 503 4 HET N6I B 501 34 HET EDO B 502 4 HET EDO B 503 4 HET EDO B 504 4 HET EDO B 505 4 HET EDO B 506 4 HET EDO B 507 4 HET EDO C 501 4 HET EDO C 502 4 HET EDO C 503 4 HET EDO C 504 4 HET EDO D 501 4 HET EDO D 502 4 HET EDO D 503 4 HET EDO D 504 4 HETNAM N6I (3M)-4-{[(2S)-2-(3-CHLOROPHENYL)-2-HYDROXYETHYL]AMINO}- HETNAM 2 N6I 3-[4-METHYL-6-(MORPHOLIN-4-YL)-1H-BENZIMIDAZOL-2- HETNAM 3 N6I YL]PYRIDIN-2(1H)-ONE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 5 N6I 2(C25 H26 CL N5 O3) FORMUL 6 EDO 16(C2 H6 O2) FORMUL 23 HOH *576(H2 O) HELIX 1 AA1 LYS A 307 LEU A 323 1 17 HELIX 2 AA2 SER A 324 LYS A 326 5 3 HELIX 3 AA3 HIS A 327 TRP A 332 1 6 HELIX 4 AA4 PRO A 333 TYR A 335 5 3 HELIX 5 AA5 ASP A 339 GLU A 344 1 6 HELIX 6 AA6 ASP A 347 ILE A 352 1 6 HELIX 7 AA7 ASP A 357 GLY A 367 1 11 HELIX 8 AA8 ASP A 372 ASN A 391 1 20 HELIX 9 AA9 HIS A 395 LYS A 414 1 20 HELIX 10 AB1 SER B 309 LEU B 323 1 15 HELIX 11 AB2 SER B 324 LYS B 326 5 3 HELIX 12 AB3 HIS B 327 TRP B 332 1 6 HELIX 13 AB4 PRO B 333 TYR B 335 5 3 HELIX 14 AB5 ASP B 339 GLU B 344 1 6 HELIX 15 AB6 ASP B 347 ILE B 352 1 6 HELIX 16 AB7 ASP B 357 GLY B 367 1 11 HELIX 17 AB8 ASP B 372 ASN B 391 1 20 HELIX 18 AB9 HIS B 395 LYS B 414 1 20 HELIX 19 AC1 SER C 309 LEU C 323 1 15 HELIX 20 AC2 SER C 324 LYS C 326 5 3 HELIX 21 AC3 HIS C 327 TRP C 332 1 6 HELIX 22 AC4 PRO C 333 TYR C 335 5 3 HELIX 23 AC5 ASP C 347 ILE C 352 1 6 HELIX 24 AC6 ASP C 357 GLY C 367 1 11 HELIX 25 AC7 ASP C 372 ASN C 391 1 20 HELIX 26 AC8 HIS C 395 LYS C 414 1 20 HELIX 27 AC9 SER D 309 LEU D 323 1 15 HELIX 28 AD1 SER D 324 LYS D 326 5 3 HELIX 29 AD2 HIS D 327 TRP D 332 1 6 HELIX 30 AD3 PRO D 333 TYR D 335 5 3 HELIX 31 AD4 ASP D 339 GLU D 344 1 6 HELIX 32 AD5 ASP D 347 ILE D 352 1 6 HELIX 33 AD6 ASP D 357 GLY D 367 1 11 HELIX 34 AD7 ASP D 372 ASN D 391 1 20 HELIX 35 AD8 HIS D 395 LYS D 414 1 20 CRYST1 104.590 92.280 64.910 90.00 99.42 90.00 C 1 2 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009561 0.000000 0.001587 0.00000 SCALE2 0.000000 0.010837 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015617 0.00000